Pelorus Breaks Credit Grass Ceiling With A Rated Notes

May 17, 2023 · Green Market Report

Cannabis debt has been typically given low ratings if receiving a rating at all. This week, cannabis commercial real estate lender Pelorus Capital Group announced that $50 million in aggregate principal amount of 7% senior secured notes due September 26, 2026 issued by its private mortgage real estate investment trust subsidiary, the Pelorus Fund REIT, have been assigned an A rating by Egan-Jones Rating Company – the highest rating issued to date in the cannabis industry.

“We are proud to achieve a cannabis-industry first by achieving an A-flat rating,” said Dan Leimel, CEO of Pelorus Capital Group (previously Pelorus Equity Group) and the manager of the Pelorus Fund. “We believe this two-step rating increase reflects our financial health and our significant growth, while securing the Notes provides more flexibility as the Pelorus Fund continues to grow and gain market share. Against a backdrop of challenging market conditions, particularly within the cannabis sector, we believe we are now even better positioned to grow our deal pipeline, strengthen our business and offer attractive lending solutions to cannabis businesses across the country.”

The Pelorus Fund issued the Notes, which were previously unsecured, in 2021 and at the time received a BBB+ rating from Egan-Jones. At the time, this was the first issued by a privately held mortgage REIT to receive what was then the highest credit rating achieved by an issuer operating within the cannabis sector. When this rating was issued in 2021, Pelorus Fund had approximately $130M in assets under management, which has nearly tripled to approximately $376M in AUM currently.

Recently, the Pelorus Fund completed a transaction to secure the Notes, which when combined with the strength of the balance sheet, successful track record, and investment income growth year-over-year resulted in Egan-Jones upgrading the BBB+ rating to an A rating. An Egan-Jones A rating is defined as having a high level of creditworthiness with low sensitivity to evolving credit conditions. (Full Story)

In category:Business
Next Post

California Cannabis Companies Form Group to Address Industry’s ‘Culture of Nonpayment’

A cohort of cannabis industry operators on Tuesday announced a coalition that seeks to raise awareness and offer solutions to severe credit issues that threaten the industry’s stability. The Financial Stability for California Cannabis (FSCC) includes Kiva Sales & Service,…
Read
Previous Post

Planet 13 Reports Q1 Loss, Maintains Nevada Market Share

Net loss for the quarter rose due to lower gross profit and high one-time costs. Las Vegas-based Planet 13 Holdings Inc. (CSE:PLTH) (OTCQB:PLNHF) posted a 3% decline in revenue for the first quarter ended March 31, which it primarily attributed to a…
Read
Random Post

Glass House Responds to “Black Marketeer” Allegations with Lawsuit

A dispute between California cannabis competitors has resulted in dueling lawsuits containing extraordinary allegations of black marketeering and reckless disregard for the truth. In a complaint filed June 20 in Los Angeles Superior Court, Glass House Brands Inc. claims Long…
Read
Random Post

GOP Congressman And AOC Refile Bill To Incentivize State-Level Marijuana Expungements

Reps. Dave Joyce (R-OH) and Alexandria Ocasio-Cortez (D-NY) have reintroduced a bipartisan bill to encourage state and local governments to expunge marijuana records in their jurisdictions. The lawmakers filed the Harnessing Opportunities by Pursuing Expungement (HOPE) Act on Tuesday, describing…
Read
Random Post

Is Cannabis Legalization Stalling Out Across America? - Rec Weed Fails in Arkansas, North Dakota, South Dakota, and Oklahoma

As the winds of change blow across the United States, many states have lifted their bans on recreational cannabis. However, not every state has embraced the green wave with open arms. Despite the growing popularity of cannabis and its proven medical…
Read
Random Post

Across The Globe: Psychedelic Trials To Treat Late-Stage Cancer, Alzheimer's Begin

Core One Labs' Akome Partners To Study Next-Gen Psychedelics A subsidiary of Core One Labs  CLABF has signed a contract with Fundació Bosh I Gimpera to begin second-phase studies evaluating the therapeutic potential of its bio-compounds (both alone and combined with psychedelic substances). The…
Read